Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

India · Delayed Price · Currency is INR

4,497.00

+27.80 (0.62%)

May 22, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Generic Formulation Business	139.80B	115.16B	107.28B	96.20B	85.08B
Generic Formulation Business Growth	21.40%	7.35%	11.51%	13.07%	6.29%
Total	139.80B	115.16B	107.28B	96.20B	85.08B
Total Growth	21.40%	7.35%	11.51%	13.07%	6.29%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	76.45B	67.88B	61.09B	53.70B	46.83B
India Growth	12.63%	11.10%	13.78%	14.66%	16.22%
Brazil	13.62B	11.00B	11.26B	9.35B	7.42B
Brazil Growth	23.78%	-2.29%	20.38%	26.07%	17.75%
United States	13.63B	11.00B	10.78B	11.62B	10.67B
United States Growth	23.93%	2.05%	-7.26%	8.89%	-15.52%
Germany	12.49B	11.39B	10.74B	9.28B	9.66B
Germany Growth	9.62%	6.09%	15.77%	-4.00%	-6.96%
Other Countries	-	13.89B	13.41B	12.25B	10.49B
Other Countries Growth	-	3.60%	9.40%	16.78%	0.59%
Total	116.19B	115.16B	107.28B	96.20B	85.08B
Total Growth	0.89%	7.35%	11.51%	13.07%	6.29%

Source: S&P Global Market Intelligence.